← FDA Drug Approvals (Drugs@FDA)
ALOGLIPTIN; METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT PHARMS LTD · Approved 2018-12-19
Drug application
- FDA Application #
ANDA210160- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ALOGLIPTIN; METFORMIN HYDROCHLORIDE
- Generic name
- Alogliptin
- Active ingredients
- ALOGLIPTIN; METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- TORRENT PHARMS LTD
- First approval
- 2018-12-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown